| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |